Kehua Bio-Engineering updates governance, increases capital, appoints auditor

Shanghai Kehua Bio-Engineering Co., Ltd. announced on October 13, 2025, the abolishment of its supervisory board, with its statutory functions to be exercised by the board's audit committee. This decision, along with changes to its registered capital and amendments to the Articles of Association, follows a review of relevant laws and internal conditions. The company's registered capital increased from 514,317,177 yuan to 514,348,244 yuan due to convertible bond conversions.

The amendments to the Articles of Association involve numerous changes, including replacing "shareholders' general meeting" with "shareholders' meeting" and "supervisory board" with "audit committee" in relevant clauses. Additionally, the company announced its intent to reappoint Rongcheng Certified Public Accountants as its auditor for 2025, with an audit fee of 140 million yuan (excluding tax) and an internal control audit fee of 30 million yuan (excluding tax), maintaining the same fees as the previous year.

These changes encompass revised internal controls, new guidelines for related-party transactions, and updated policies for director compensation, investment, and information disclosure. The restructuring aims to improve decision-making efficiency and ensure compliance with the latest regulations, reinforcing the company's commitment to robust governance.